Holen Sie sich die Stockscreener-App
0.11
90.76%
-1.08
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ORGS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.19
Offen:
$0.7499
24-Stunden-Volumen:
120
Relative Volume:
1.60
Marktkapitalisierung:
$N/A
Einnahmen:
$662.00K
Nettoeinkommen (Verlust:
$-29.02M
KGV:
-0.0129
EPS:
-8.5
Netto-Cashflow:
$-12.54M
1W Leistung:
-90.76%
1M Leistung:
-90.76%
6M Leistung:
-76.19%
1J Leistung:
-86.10%
1-Tages-Spanne:
$0.7499
$0.7499
1-Wochen-Bereich:
$0.7499
$0.7499
52-Wochen-Spanne:
$0.7499
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
Vergleichen Sie ORGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.7499 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
ARGX
Argen X Se Adr
|
921.68 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.78 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
198.03 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
357.90 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
712.45 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-20 | Eingeleitet | Dawson James | Buy |
Orgenesis Inc Aktie (ORGS) Neueste Nachrichten
Is Orgenesis Inc. (45O) stock suitable for passive index fundsMarket Weekly Review & Reliable Volume Spike Trade Alerts - newser.com
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockTrade Signal Summary & High Win Rate Trade Tips - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsQuarterly Trade Review & High Win Rate Trade Tips - newser.com
How Orgenesis Inc. (45O) stock compares with top peersWatch List & Trade Opportunity Analysis - newser.com
Will Orgenesis Inc. (45O) stock beat international competitionWeekly Market Report & Low Volatility Stock Recommendations - newser.com
Genital Warts Treatment Market Set to Explode from 2025 to 2032 - openPR.com
What analysts say about Orgenesis Inc 45O stockMarket Capitalization Trends & Breakout Stock Alerts - earlytimes.in
Is Orgenesis Inc 45O a good long term investmentTechnical Resistance Breaks & Stay One Step Ahead of Risk Events - earlytimes.in
Why Orgenesis Inc. (45O) stock gets analyst attentionQuarterly Market Summary & AI Driven Price Predictions - fcp.pa.gov.br
Why Orgenesis Inc. (45O) stock remains top ratedWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Finanzdaten der Orgenesis Inc-Aktie (ORGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.53%
Kapitalisierung:
|
Volumen (24h):